“The chest X-ray not only cleared particularly, but the vital markers of inflammation, IL-6 and ferratin, decreased after 4 days of treatment. It is known that the photobiomodulation cure has anti-inflammatory effects, but in this case it treated patient breathing well. symptoms, “said Dr. Sigman. ” As of the time of patient publication of our trial, we hope that this knowledge will inspire others to PBMT as an adjunct remedy option and assist further clinical trials with the use of supplemental PBMT for COVID-19. As we know, there is a constant medical need for safe and effective COVID-19 remedy options. “
The patient, a 32-year-old Asian woman diagnosed with SARS-CoV-2, was treated with 28-minute PBMT sessions once a day for 4 days with a laser treatment with Multiwave Locked system 40 System (ASA) FDA-approved 41st. Italy). The MLS treatment laser used in this study is distributed exclusively in North America through Cutting Edge Laser Technologies, founded in Rochester, New York. The patient’s reaction to PBMT was assessed by comparing other scoring equipment before and after laser treatment, all of which took a step forward after The effects showed an increase in oxygen saturation (88 to 93% to 97%), an improvement in RALE score on chest x-rays (8 to 3) and a minimization of inflammatory markers: IL-degrees 6 (45. 89 pg / ml at 11. 7 pg / ml) PCR (3. 06 mg / dl at 1. 43 mg / dl) and ferratine grades (359 ng / ml to 175 ng / ml).